The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.
Recent research data indicates the global psychedelic drugs market was valued at $2.6 billion in 2022 and is forecasted to reach $7.1 billion by 2032, reflecting massive growth at a CAGR of 10.9%.
